Royal Bank of Canada Has Lowered Expectations for Addus HomeCare (NASDAQ:ADUS) Stock Price

Addus HomeCare (NASDAQ:ADUS) had its price target decreased by research analysts at Royal Bank of Canada from $141.00 to $136.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s price target points to a potential upside of 5.36% from the stock’s previous close.

A number of other analysts have also weighed in on ADUS. Stephens reaffirmed an “overweight” rating and issued a $138.00 price objective on shares of Addus HomeCare in a research note on Tuesday, August 6th. KeyCorp initiated coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Macquarie reissued an “outperform” rating and set a $139.00 price objective on shares of Addus HomeCare in a report on Monday. Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Finally, TD Cowen lifted their price target on Addus HomeCare from $128.00 to $137.00 and gave the company a “buy” rating in a report on Thursday, August 8th. One equities research analyst has rated the stock with a sell rating, eight have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $131.63.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $129.08 on Wednesday. The company has a market capitalization of $2.34 billion, a PE ratio of 29.54, a P/E/G ratio of 2.33 and a beta of 1.04. The company has a 50 day moving average price of $129.71 and a 200-day moving average price of $120.97. Addus HomeCare has a fifty-two week low of $81.51 and a fifty-two week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 10.12% and a net margin of 6.50%. The business had revenue of $289.80 million during the quarter, compared to analyst estimates of $289.42 million. During the same period in the previous year, the company posted $1.03 EPS. Addus HomeCare’s revenue was up 7.1% on a year-over-year basis. On average, analysts forecast that Addus HomeCare will post 4.57 earnings per share for the current year.

Insider Transactions at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 21,917 shares of the firm’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the sale, the executive vice president now owns 7,215 shares of the company’s stock, valued at $961,687.35. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, EVP Michael D. Wattenbarger sold 21,917 shares of the stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $133.29, for a total value of $2,921,316.93. Following the completion of the transaction, the executive vice president now directly owns 7,215 shares of the company’s stock, valued at $961,687.35. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Esteban Lopez sold 500 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $127.50, for a total transaction of $63,750.00. Following the completion of the transaction, the director now directly owns 3,366 shares of the company’s stock, valued at approximately $429,165. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 22,917 shares of company stock valued at $3,050,082. Corporate insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ADUS. Texas Permanent School Fund Corp boosted its position in Addus HomeCare by 0.6% in the second quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after buying an additional 82 shares during the last quarter. Arizona State Retirement System lifted its stake in Addus HomeCare by 2.0% during the 2nd quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after acquiring an additional 87 shares during the period. UMB Bank n.a. boosted its holdings in shares of Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares during the last quarter. Inspire Investing LLC increased its stake in shares of Addus HomeCare by 3.3% in the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after acquiring an additional 100 shares during the period. Finally, New York State Teachers Retirement System raised its holdings in shares of Addus HomeCare by 1.2% during the third quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after purchasing an additional 100 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.